Bank of Montreal’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-163
Closed -$8K 5426
2020
Q4
$8K Hold
163
﹤0.01% 4709
2020
Q3
$9K Buy
+163
New +$9.66K ﹤0.01% 4194
2019
Q1
Sell
-867
Closed -$137K 4851
2018
Q4
$137K Buy
867
+476
+122% +$91.2K ﹤0.01% 2780
2018
Q3
$96K Sell
391
-1,235
-76% -$292K ﹤0.01% 3113
2018
Q2
$364K Buy
+1,626
New +$435K ﹤0.01% 2481

Other funds holding DMK

Bank of Montreal's DMK Position: Q1 2021 in Review

Bank of Montreal sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2021, closing a stake of 163 shares — an estimated $8K sold.

Bank of Montreal first reported a position in DMK in Q2 2018 and held it in 5 quarters. The position peaked at $364K in Q2 2018. 53 funds tracked by Wall St. Rank hold DMK as of Q1 2021.

  • Bank of Montreal reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2021 after selling out during the quarter.
  • Bank of Montreal sold 163 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2021, an estimated $8K.
  • Bank of Montreal first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2018 and held it in 5 quarters.
  • Bank of Montreal's DMK Pharmaceuticals Corporation Common Stock position peaked at $364K in Q2 2018.
  • 53 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2021.

Based on Bank of Montreal's 13F filing for Q1 2021, filed 13 May 2021.